Guardian Pharmacy Services, Inc.
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 4.51% | -15.35% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.51% | -15.35% | |||
| Cost of Revenue | 4.39% | -16.61% | |||
| Gross Profit | 4.89% | -10.75% | |||
| SG&A Expenses | 22.32% | 10.56% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.54% | -12.85% | |||
| Operating Income | -41.36% | -40.97% | |||
| Income Before Tax | 62.86% | -41.18% | |||
| Income Tax Expenses | 61.53% | -51.71% | |||
| Earnings from Continuing Operations | 63.33% | -36.31% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | 27.19% | |||
| Net Income | 64.51% | -36.46% | |||
| EBIT | -41.36% | -40.97% | |||
| EBITDA | -32.78% | -34.67% | |||
| EPS Basic | 64.48% | -36.44% | |||
| Normalized Basic EPS | -0.48% | -40.00% | |||
| EPS Diluted | 64.16% | -36.55% | |||
| Normalized Diluted EPS | -0.72% | -40.07% | |||
| Average Basic Shares Outstanding | 0.01% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.22% | 0.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||